Screener
Sarepta Therapeutics, Inc. SRPT Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s return on equity?
- Sarepta Therapeutics, Inc. (SRPT) reported return on equity of -9.3% in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s return on equity changed year-over-year?
- Sarepta Therapeutics, Inc.'s return on equity decreased by 99.7% year-over-year, from -4.7% to -9.3%.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s return on equity?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s return on equity has grown at a -5.3% compound annual growth rate (CAGR), from -70.1% to -53.5%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Sarepta Therapeutics, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude